Prevalence of EILO Among Children With Asthma

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorMedisch Spectrum Twente

About this trial

The goal of this cross-sectional study is to investigate the prevalence of Exercise Induced Laryngeal Obstruction (EILO) in children with asthma.

The hypothesis is that the prevalence will be around 15%, which is higher than the prevalence of 5-8% among the general adolescent population. This is based on the increased prevalence of EILO among adult asthmatics.

Participants who are referred for an Exercise Challenge Test will perform an additional Continuous Laryngoscopy during Exercise Test with expiratory FEV1 curves, and fill in the Borg scale for dyspnea, Asthma Control Test, EILODI questionnaire and DISCO-RC questionnaire.

Eligibility criteria

Qualifiers

Age 12 to 18 years

Paediatrician diagnosed asthma confirmed with at least one of the following during the last two years: Positive ECT (post-exercise fall in FEV1 > 10%) / Positive methacholine test (PC20 value of ≤8 mg/mL) / Bronchodilator reversibility (increase in FEV1 ≥12% and/or ≥200 mL following inhalation of 200-400 μg short-acting β2-agonists)

Disqualifiers

Other severe cardiopulmonary disease

Inability to perform ECT or CLE test

Inability to perform technically acceptable spirometry

Asthma exacerbation or respiratory tract infection in the last 2 weeks

Trial design

Treatments tested in this trial

  • Continuous Laryngoscopy during Exercise Test (CLE test)

Treatment groups

No treatment groups listed

Sponsors and collaborators

Medisch Spectrum Twente

Lead sponsor

Haukeland University Hospital

Collaborator